Communiqués BRAIN Biotech AG BOERSE MUENCHEN

Actions

BNN

DE0005203947

Temps réel BOERSE MUENCHEN Autres places de cotation 08:00:43 17/07/2024			Varia. 5j.	Varia. 1 janv.
2,35 ^EUR	0,00%		+7,80%	-36,83%

28/05	BRAIN Biotech AG annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024	CI
05/03	BRAIN Biotech AG et AMSilk GmbH annoncent la réussite de la première phase d'une collaboration de développement	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes	29/05	EQ
BRAIN Biotech : receives major milestone payment and stays on-track to achieve year end targets	28/05	PU
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets	28/05	EQ
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	14/05	EQ
BRAIN Biotech AG takes next step to optimize group structure	16/04	EQ
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams	14/03	EQ
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG	12/03	EQ
Collaboration between BRAIN Biotech and AMSilk, Protein engineering successfully improves structural proteins for performance materials	06/03	AQ
BRAIN Biotech : Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying	05/03	PU
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials	05/03	EQ
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives	29/02	EQ
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights	29/02	EQ
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24	28/02	EQ
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy	17/01	EQ
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	10/01	EQ
BRAIN Biotech : ESG Data Sheet 2023	14/12	PU
Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy	20/11	EQ
BRAIN Biotech : High-performance production strains for enzymes and proteins	06/11	PU
BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition	28/09/23	EQ
BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®	14/09/23	EQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BRAIN Biotech AG BOERSE MUENCHEN

Actions

BNN

DE0005203947

Communiqués

Filtres